A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer
Principal Investigator
Gregory M. Videtic, MD CM
Status
Terminated
Date Opened To Accrual
September 03 2009
Date Closed to Accrual
March 22 2011
Date of Study Termination
May 14 2018
Disease Site
Lung [LU]
Non-small Cell Lung Cancer
Phase
II
Developmental Therapeutics
No
Primary Objective
The rate of 1-year grade 3 or higher adverse events definitely, probably, or possibly related to treatment
Data Collection Notice:
Data for this trial is being collected via the NRG/RTOG Data Center.
Patient Population
luMedically inoperable, biopsy proven early stage T1, T2 (< 5 cm) NSCLC patients; clinically node negative by PET, with peripherally located tumors (> 2 cm in all directions around the proximal bronchial tree)
Target Accrual
88
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.